Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
365
-
Total 13F shares, excl. options
-
36.8M
-
Shares change
-
-2.38M
-
Total reported value, excl. options
-
$4.93B
-
Value change
-
-$289M
-
Put/Call ratio
-
0.66
-
Number of buys
-
218
-
Number of sells
-
-144
-
Price
-
$134.01
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q2 2025
425 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q2 2025.
TransMedics Group, Inc. - Common Stock (TMDX) has 365 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.8M shares
.
Largest 10 shareholders include BlackRock, Inc. (5.22M shares), FMR LLC (5.02M shares), VANGUARD GROUP INC (3.6M shares), STATE STREET CORP (1.29M shares), FIL Ltd (1.06M shares), UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC (956K shares), MACQUARIE GROUP LTD (952K shares), Driehaus Capital Management LLC (854K shares), GEODE CAPITAL MANAGEMENT, LLC (805K shares), and MORGAN STANLEY (733K shares).
This table shows the top 365 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.